Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
I
118TH CONGRESS
1ST SESSION H. R. 2853
To amend title XVIII of the Social Security Act to expand access to clinical
care in the home, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
APRIL 25, 2023
Mr. SMITH of Nebraska (for himself and Mrs. DINGELL) introduced the fol-
lowing bill; which was referred to the Committee on Energy and Com-
merce, and in addition to the Committee on Ways and Means, for a pe-
riod to be subsequently determined by the Speaker, in each case for con-
sideration of such provisions as fall within the jurisdiction of the com-
mittee concerned
A BILL
To amend title XVIII of the Social Security Act to expand
access to clinical care in the home, and for other purposes.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.
3
(a) SHORT TITLE.—This Act may be cited as the
4
‘‘Expanding Care in the Home Act’’.
5
(b) TABLE OF CONTENTS.—the table of contents of
6
this Act is as follows:
7
Sec. 1. Short title; table of contents.
Sec. 2. Enhancing primary care in the home.
Sec. 3. Improving coverage for Medicare home infusion.
VerDate Sep 11 2014
01:31 May 03, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6211
E:\BILLS\H2853.IH
H2853
SSpencer on DSK30NT082PROD with BILLS
2
•HR 2853 IH
Sec. 4. Establishing payment for staff-assisted home dialysis.
Sec. 5. Ensuring Medicare beneficiaries have access to in-home labs.
Sec. 6. Expanding advanced diagnostic imaging in the home.
Sec. 7. Delivering personal care services to Medicare beneficiaries.
Sec. 8. Building the future of the home-based care workforce.
SEC. 2. ENHANCING PRIMARY CARE IN THE HOME.
1
(a) IN GENERAL.—The Secretary of Health and
2
Human Services (HHS Secretary) shall allow primary
3
care providers (PCPs) enrolled in Medicare Part B to elect
4
to receive a monthly capitated payment for Primary Care
5
Qualified Evaluation and Management Services (PQEM)
6
as an alternative to fee-for-service reimbursement. Pro-
7
viders shall be allowed to elect to receive a monthly
8
capitated payment for a period of time ranging from one
9
to five years.
10
(b) COVERED SERVICES.—The HHS Secretary shall
11
annually identify PQEM services no later than October 1
12
each year. At a minimum, these services shall include the
13
following services when billed by a primary care provider
14
or a nonprimary care specialist (as outlined by the Sec-
15
retary):
16
(1)
Office
or
Other
Outpatient
Services
17
(99201–99205, 99211–99215).
18
(2) Domiciliary, Rest Home or Custodial Care
19
Services (99324–99328, 99334–99337).
20
(3) Domiciliary, Rest Home or Home Care Plan
21
Oversight Services 99339–99340).
22
VerDate Sep 11 2014
01:31 May 03, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H2853.IH
H2853
SSpencer on DSK30NT082PROD with BILLS
3
•HR 2853 IH
(4) Home Services (99341–99345, 99347–
1
99350).
2
(5) Transitional Care Management Services
3
(99495–99496).
4
(6) Care Coordination Management Services
5
(99490).
6
(7) Wellness Visits (G0402, G0438, G0439).
7
(c) PAYMENT.—The capitated payment system de-
8
signed by the HHS Secretary shall have the following:
9
(1) Base capitated payments should reflect the
10
previous 3 years excluding the period during which
11
there was an active public health emergency for
12
COVID–19.
13
(2) There should be an increase in payments to
14
reflect the need for PCPs to invest in changing their
15
office practice workflow.
16
(3) Higher PCP payment could be possible
17
through greater bonuses related to improving value
18
through total cost of care and quality.
19
(4) PCPs electing capitated payments should be
20
permitted to offer incentives to engage patients to be
21
assigned to their patient care panels.
22
(d) ATTRIBUTION.—The HHS Secretary shall ensure
23
that PCPs electing to receive a capitated payment have
24
visibility and input into the attribution model used to at-
25
VerDate Sep 11 2014
01:31 May 03, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H2853.IH
H2853
SSpencer on DSK30NT082PROD with BILLS
4
•HR 2853 IH
tribute patients to them. At a minimum, the attribution
1
methodology should—
2
(1) patient attribution to panels should be pro-
3
spective;
4
(2) panels should be updated monthly or quar-
5
terly; and
6
(3) PCPs should have a mechanism and incen-
7
tives to enroll patients so they can influence who is
8
attributed to their panel.
9
SEC. 3. IMPROVING COVERAGE FOR MEDICARE HOME IN-
10
FUSION.
11
(a) IN GENERAL.—The HHS Secretary shall estab-
12
lish reimbursement for home infusion services and associ-
13
ated equipment and items under part B.
14
(b) COVERED SERVICES AND SUPPLIES.—Home In-
15
fusion Therapy (HIT) and associated equipment are de-
16
fined to include—
17
(1) equipment (e.g., mechanical pumps) for
18
drug administration of Eligible Infusion Drugs;
19
(2) items (other than drugs and equipment)
20
used in connection with the delivery of Eligible Infu-
21
sion Drugs such as disposable supplies for the drug
22
administration (e.g., tubing, elastomeric pumps) and
23
for the routine maintenance of the infusion access
24
device;
25
VerDate Sep 11 2014
01:31 May 03, 2023
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H2853.IH
H2853
SSpencer on DSK30NT082PROD with BILLS
5
•HR 2853 IH
(3) 24/7 availability of pharmacist professional
1
services such as assessments, drug preparation and
2
compounding, dispensing, clinical monitoring, ad-
3
ministrative, and education; and
4
(4) 24/7 availability of nursing services (when
5
not provided as part of a home health episode).
6
(c) QUALIFIED PROVIDERS.—Provided by a qualified
7
home infusion therapy services supplier as defined in sec-
8
tion 1861(iii)(3)(C) of this Act.
9
(d) ELIGIBLE INFUSION DRUGS.—Eligible part B
10
and part D Infusion Drugs are defined as parenteral
11
drugs or biologics administered through intravenous,
12
intrathecal, intra-arterial, or subcutaneous access device,
13
except—
14
(1) drugs and biologics on the self-administered
15
drug list; and
16
(2) drugs and biologics covered under Part B
17
Durable Medical Equipment, Prosthetics, Orthotics
18
and Supplies (DMEPOS).
19
(e) CURRENT OR FUTURE INFUSION DRUGS.—Pro-
20
vided, nothing in this section shall be construed to change
21
the coverage status of any current or future infusion drugs
22
that meet the definition of a covered part D drug as de-
23
fined at section 1860D–2(e) and which are paid under
24
Medicare part D.
25
VerDate Sep 11 2014
01:31 May 03, 2023
Jkt 039200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H2853.IH
H2853
SSpencer on DSK30NT082PROD with BILLS
6
•HR 2853 IH
(f) REFERRING
PROVIDERS.—Patients must be
1
under the care of a physician, nurse practitioner, or physi-
2
cian assistant.
3
(g) SAFETY AND QUALITY.—Consistent with stand-
4
ards of care found within commercial, Medicare Advan-
5
tage, and State Medicaid programs with regard to sterile
6
preparation of the drug to a final, useable form; timeliness
7
of initiation of care; billing of drugs, items, and pharmacy
8
services by a single entity; performing periodic assess-
9
ments of patient satisfaction and collection and evaluation
10
of quality outcome data; and maintaining a consolidated
11
patient record of services provided in accordance with the
12
plan of care.
13
(h)(1) REIMBURSEMENT.—A per infusion day pay-
14
ment is established and defined as ‘‘a payment for the
15
date on which a drug was administered to the individual
16
at home (regardless of whether a skilled professional was
17
physically present in the home of such individual on such
18
date)’’.
19
(2) MARKET RATES.—Such payment may be based
20
on a market analysis of rates paid for home infusion sup-
21
plies and services by the commercial sector and Medicare
22
Advantage programs.
23
(3) PAYMENT ELIGIBILITY.—Nothing shall prevent a
24
home infusion supplier from being paid a per infusion day
25
VerDate Sep 11 2014
01:31 May 03, 2023
Jkt 039200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H2853.IH
H2853
SSpencer on DSK30NT082PROD with BILLS
7
•HR 2853 IH
payment when a qualified home health agency provides the
1
nursing services for the infusion therapy under the part
2
A home health benefit.
3
SEC. 4. ESTABLISHING PAYMENT FOR STAFF-ASSISTED
4
HOME DIALYSIS.
5
(a) IN GENERAL.—Section 1881(b)(14) of the Social
6
Security Act (42 U.S.C. 1395rr(b)(14)) is amended by
7
adding at the end the following new subparagraph:
8
‘‘(J)(i) For services furnished on or after
9
the date which is 1 year after the date of the
10
enactment of this subparagraph which are staff-
11
assisted home dialysis (as defined in clause
12
(iv)(III)), the Secretary shall increase the single
13
payment that would otherwise apply under this
14
paragraph for renal dialysis services furnished
15
to new and respite individuals in accordance
16
with the payment system established under
17
clause (iii) by qualified providers.
18
‘‘(ii)(I) Subject to subclause (II), staff-as-
19
sisted home dialysis may only be furnished dur-
20
ing—
21
‘‘(aa) with respect to an individual de-
22
scribed in subclause (iv)(I)(aa), one 90-day
23
period which may be renewed up to two
24
30-day periods; and
25
VerDate Sep 11 2014
01:31 May 03, 2023
Jkt 039200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H2853.IH
H2853
SSpencer on DSK30NT082PROD with BILLS
8
•HR 2853 IH
‘‘(bb) with respect to an individual de-
1
scribed in subclause (iv)(I)(bb) and not-
2
withstanding whether such an individual
3
receives any respite care under part A, any
4
30-day period.
5
‘‘(II) Notwithstanding the limits described
6
in subclause (I), staff-assisted home dialysis
7
may be furnished for as long as the Secretary
8
determines appropriate to an individual who—
9
‘‘(aa) is blind;
10
‘‘(bb) has a cognitive or neurological
11
impairment
(including
a
stroke,
Alz-
12
heimer’s, dementia amyotrophic lateral
13
sclerosis, or any other impairment deter-
14
mined by the Secretary); or
15
‘‘(cc) has any other illness or injury
16
that reduces mobility (including cerebral
17
palsy, spinal cord injuries, or any other ill-
18
ness or injury determined by the Sec-
19
retary).
20
‘‘(iii) The Secretary shall establish a pro-
21
spective payment system through regulations to
22
determine the amounts payable to qualified pro-
23
viders for staff-assisted home dialysis. In estab-
24
VerDate Sep 11 2014
01:31 May 03, 2023
Jkt 039200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H2853.IH
H2853
SSpencer on DSK30NT082PROD with BILLS
9
•HR 2853 IH
lishing such system, the Secretary may con-
1
sider—
2
‘‘(I) the costs of furnishing staff-as-
3
sisted home dialysis;
4
‘‘(II) consultations with dialysis pro-
5
viders, dialysis patients, private payers,
6
and MA plans;
7
‘‘(III) payment amounts for similar
8
items and services under parts A and B;
9
and
10
‘‘(IV) payment amounts established
11
by MA plans under part C, group health
12
plans, and health insurance coverage of-
13
fered by health insurance issuers.
14
‘‘(iv) In this subparagraph:
15
‘‘(I) The term ‘new and respite indi-
16
vidual’ means an individual described in
17
subsection (a) who is either—
18
‘‘(aa) initiating either peritoneal
19
or home hemodialysis; or
20
‘‘(bb) receiving home dialysis and
21
is unable to self-dialyze due to illness,
22
injury, caregiver issues, or other tem-
23
porary circumstances.
24
VerDate Sep 11 2014
01:31 May 03, 2023
Jkt 039200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H2853.IH
H2853
SSpencer on DSK30NT082PROD with BILLS
10
•HR 2853 IH
‘‘(II) The term ‘qualified provider’
1
means a trained professional (as deter-
2
mined by the Secretary, including nurses
3
and certified patient technicians) who fur-
4
nishes renal dialysis services and—
5
‘‘(aa) meets requirements (as de-
6
termined by the Secretary) that en-
7
sures competency in patient care and
8
modality usage; and
9
‘‘(bb) provides in-person assist-
10
ance to a patient for at least 75 per-
11
cent of staff-assisted home dialysis
12
sessions during a period described in
13
clause (ii)(i).
14
‘‘(III)(aa) The term ‘staff-assisted
15
home dialysis’ means home dialysis using
16
trained professionals to assist individuals
17
who have been determined to have end
18
stage renal disease, and the frequency of
19
such home dialysis is determined by such
20
professionals in coordination with the pa-
21
tient and his or her care partner, and out-
22
lined in a patient plan of care.
23
‘‘(bb) In this subclause, the term ‘care
24
partner’ means anyone who is designated
25
VerDate Sep 11 2014
01:31 May 03, 2023
Jkt 039200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H2853.IH
H2853
SSpencer on DSK30NT082PROD with BILLS
11
•HR 2853 IH
by the patient who assists the individual
1
with the furnishing of home dialysis.
2
‘‘(cc) In this subclause, the term ‘pa-
3
tient plan of care’ has the meaning given
4
such term in section 494.90 of title 42,
5
Code of Federal Regulations.’’.
6
(b) PATIENT EDUCATION AND TRAINING RELATING
7
TO
STAFF-ASSISTED
HOME
DIALYSIS.—Section
8
1881(b)(5) of the Social Security Act (42 U.S.C.
9
1395rr(b)(5)) is amended—
10
(1) in subparagraph (C), by striking at the end
11
‘‘and’’;
12
(2) in subparagraph (D), by striking the period
13
at the end and inserting a semicolon; and
14
(3) by adding at the end the following new sub-
15
paragraphs:
16
‘‘(D) educate patients of the opportunity to
17
receive staff-assisted home dialysis (as defined
18
in paragraph (14)(J)(iv)(III)) during the period
19
beginning 30 days after the first day such facil-
20
ity furnishes renal dialysis services to an indi-
21
vidual and ending 60 days after such day; and
22
‘‘(E) provide for nurses, certified patient
23
technicians, or other professionals to train pa-
24
tients and their care partners in skills and pro-
25
VerDate Sep 11 2014
01:31 May 03, 2023
Jkt 039200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H2853.IH
H2853
SSpencer on DSK30NT082PROD with BILLS
12
•HR 2853 IH
cedures needed to perform home dialysis (as de-
1
fined in paragraph (14)(J)(iv)(III)) treat-
2
ment—
3
‘‘(i) regularly and independently;
4
‘‘(ii) through telehealth services or
5
through group training (as described in the
6
interpretive guidance relating to tag num-
7
ber V590 of ‘Advance Copy—End Stage
8
Renal Disease (ESRD) Program Interpre-
9
tive Guidance Version 1.1’ (published on
10
October 3, 2008)) in accordance with the
11
Federal regulations (concerning the privacy
12
of individually identifiable health informa-
13
tion) promulgated under section 264(c) of
14
the Health Insurance Portability and Ac-
15
countability Act of 1996; and
16
‘‘(iii) in the home or resident of a pa-
17
tient, in a dialysis facility, or the place i
[Text truncated for display. Full text available on Congress.gov.]